|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
1.000
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.998
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.997
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.997
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.996
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.994
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.994
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.994
|
|
|
|
metanephric glomerular mesangium development
|
GO:0072223 |
3 |
0.992
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.992
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.990
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.990
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.988
|
|
|
|
positive regulation of smooth muscle cell migration
|
GO:0014911 |
4 |
0.986
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.985
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.983
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.983
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.983
|
|
|
|
dendritic cell differentiation
|
GO:0097028 |
26 |
0.982
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.981
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.981
|
|
|
|
regulation of chemokine secretion
|
GO:0090196 |
4 |
0.980
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.978
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.977
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.977
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.977
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.977
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.976
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.976
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.976
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.975
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.975
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.974
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.973
|
|
|
|
regulation of osteoclast differentiation
|
GO:0045670 |
36 |
0.973
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.971
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.970
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.970
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.969
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.968
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.967
|
|
|
|
microglia differentiation
|
GO:0014004 |
2 |
0.966
|
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.966
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.965
|
|
|
|
keratinocyte proliferation
|
GO:0043616 |
21 |
0.963
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.963
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.962
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.959
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.959
|
|
|
|
ovarian follicle development
|
GO:0001541 |
40 |
0.958
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.958
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.957
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.956
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.955
|
|
|
|
macrophage differentiation
|
GO:0030225 |
20 |
0.954
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.954
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.954
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.953
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.953
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.953
|
|
|
|
bone resorption
|
GO:0045453 |
38 |
0.951
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.950
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.950
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.950
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.950
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.949
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.949
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.949
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.949
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.949
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.948
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.948
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.947
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.946
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.944
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.943
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.942
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.942
|
|
|
|
platelet derived growth factor receptor signaling pathway
|
GO:0048008 |
32 |
0.940
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.939
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.937
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.936
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.936
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.935
|
|
|
|
regulation of vitamin d biosynthetic process
|
GO:0060556 |
1 |
0.934
|
|
|
|
positive regulation of chemotaxis
|
GO:0050921 |
38 |
0.932
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.930
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.930
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.929
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.929
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.924
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.919
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.919
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.918
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.918
|
|
|
|
smooth muscle cell migration
|
GO:0014909 |
10 |
0.917
|
|
|
|
positive regulation of chemokine secretion
|
GO:0090197 |
4 |
0.915
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.915
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.914
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.913
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.913
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.911
|
Human |
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.910
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.908
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.907
|
|
|
|
embryonic hemopoiesis
|
GO:0035162 |
23 |
0.903
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.902
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.901
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.901
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.901
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.900
|
|
|
|
positive regulation of apoptotic process involved in mammary gland involution
|
GO:0060058 |
4 |
0.899
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.899
|
|
|
|
jak stat cascade
|
GO:0007259 |
42 |
0.898
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.894
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.894
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.893
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.891
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.890
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.887
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.886
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.886
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.885
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.884
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.884
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.884
|
|
|
|
response to hyperoxia
|
GO:0055093 |
2 |
0.882
|
|
|
|
glycolipid metabolic process
|
GO:0006664 |
25 |
0.881
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.880
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.877
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.873
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.873
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.871
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.870
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.867
|
|
|
|
regulation of blood coagulation
|
GO:0030193 |
28 |
0.866
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.864
|
|
|
|
regulation of tissue remodeling
|
GO:0034103 |
38 |
0.859
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.859
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.858
|
|
|
|
salivary gland morphogenesis
|
GO:0007435 |
33 |
0.857
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.857
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
61 |
0.857
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.856
|
|
|
|
positive regulation of insulin receptor signaling pathway
|
GO:0046628 |
4 |
0.855
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.854
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.853
|
|
|
|
platelet derived growth factor receptor alpha signaling pathway
|
GO:0035790 |
3 |
0.853
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.852
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.851
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.850
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.848
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.847
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.845
|
|
|
|
positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090100 |
43 |
0.845
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.843
|
|
|
|
response to cholesterol
|
GO:0070723 |
4 |
0.843
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.838
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.833
|
|
|
|
maternal placenta development
|
GO:0001893 |
20 |
0.830
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.828
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.826
|
|
|
|
dna biosynthetic process
|
GO:0071897 |
22 |
0.823
|
|
|
|
granulocyte migration
|
GO:0097530 |
43 |
0.822
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.821
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.821
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.820
|
|
|
|
regulation of odontogenesis of dentin containing tooth
|
GO:0042487 |
11 |
0.820
|
|
|
|
myeloid dendritic cell activation
|
GO:0001773 |
25 |
0.817
|
|
|
|
hair cycle phase
|
GO:0044851 |
16 |
0.817
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.815
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.814
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.814
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.814
|
|
|
|
platelet derived growth factor receptor beta signaling pathway
|
GO:0035791 |
4 |
0.813
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.812
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.810
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.809
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.808
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.807
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.807
|
|
|
|
regulation of macrophage chemotaxis
|
GO:0010758 |
8 |
0.807
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.807
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.805
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.801
|
|
|
|
positive regulation of lipid kinase activity
|
GO:0090218 |
11 |
0.798
|
|
|
|
myeloid dendritic cell differentiation
|
GO:0043011 |
16 |
0.797
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.794
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
33 |
0.794
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.788
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.788
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.782
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.780
|
|
|
|
positive regulation of t cell proliferation
|
GO:0042102 |
52 |
0.779
|
|
|
|
cellular response to erythropoietin
|
GO:0036018 |
1 |
0.778
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.776
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.773
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.770
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.769
|
|
|
|
regulation of type 2 immune response
|
GO:0002828 |
18 |
0.766
|
|
|
|
actin cytoskeleton reorganization
|
GO:0031532 |
21 |
0.766
|
|
|
|
regulation of insulin receptor signaling pathway
|
GO:0046626 |
21 |
0.765
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.763
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.761
|
|
|
|
keratinocyte migration
|
GO:0051546 |
3 |
0.761
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.759
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.755
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.755
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.752
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.752
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.751
|
|
|
|
metanephric glomerular capillary formation
|
GO:0072277 |
3 |
0.749
|
|
|
|
metanephric glomerulus morphogenesis
|
GO:0072275 |
3 |
0.749
|
|
|
|
decidualization
|
GO:0046697 |
10 |
0.747
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.742
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.741
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.740
|
|
|
|
response to corticosteroid
|
GO:0031960 |
20 |
0.740
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.733
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.733
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.731
|
|
|
|
positive regulation of tyrosine phosphorylation of stat protein
|
GO:0042531 |
15 |
0.731
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.726
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.722
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.718
|
|
|
|
lipopolysaccharide mediated signaling pathway
|
GO:0031663 |
25 |
0.717
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.717
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.716
|
|
|
|
response to increased oxygen levels
|
GO:0036296 |
2 |
0.715
|
|
|
|
luteinization
|
GO:0001553 |
8 |
0.713
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.713
|
|
|
|
negative regulation of b cell differentiation
|
GO:0045578 |
4 |
0.712
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.710
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.707
|
|
|
|
positive regulation of myeloid cell differentiation
|
GO:0045639 |
43 |
0.706
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.705
|
|
|
|
cell migration involved in coronary angiogenesis
|
GO:0060981 |
1 |
0.705
|
|
|
|
dendritic cell cytokine production
|
GO:0002371 |
3 |
0.704
|
|
|
|
tyrosine phosphorylation of stat protein
|
GO:0007260 |
23 |
0.703
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.703
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.702
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.700
|
|
|
|
positive regulation of metanephric mesenchymal cell migration by platelet derived growth factor receptor beta signaling pathway
|
GO:0035793 |
1 |
0.700
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.697
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.695
|
|
|
|
cytokine production involved in immune response
|
GO:0002367 |
34 |
0.695
|
|
|
|
lymphocyte migration
|
GO:0072676 |
26 |
0.695
|
|
|
|
response to interleukin 1
|
GO:0070555 |
11 |
0.694
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.693
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.692
|
|
|
|
regulation of cell shape
|
GO:0008360 |
39 |
0.692
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.691
|
|
|
|
tyrosine phosphorylation of stat5 protein
|
GO:0042506 |
9 |
0.690
|
|
|
|
positive regulation of metanephric mesenchymal cell migration
|
GO:2000591 |
1 |
0.689
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.687
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.683
|
|
|
|
salivary gland development
|
GO:0007431 |
37 |
0.673
|
|
|
|
regulation of bone resorption
|
GO:0045124 |
24 |
0.672
|
|
|
|
tyrosine phosphorylation of stat3 protein
|
GO:0042503 |
12 |
0.670
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.669
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.666
|
|
|
|
metanephric glomerular mesangial cell proliferation involved in metanephros development
|
GO:0072262 |
3 |
0.666
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.665
|
|
|
|
cell migration involved in vasculogenesis
|
GO:0035441 |
2 |
0.661
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.660
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.659
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.658
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.658
|
|
|
|
regulation of smooth muscle cell migration
|
GO:0014910 |
6 |
0.654
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.653
|
|
|
|
positive regulation of osteoblast differentiation
|
GO:0045669 |
34 |
0.652
|
|
|
|
modification by symbiont of host morphology or physiology
|
GO:0044003 |
4 |
0.648
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.645
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.645
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.644
|
|
|
|
positive regulation of jak stat cascade
|
GO:0046427 |
22 |
0.638
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
46 |
0.636
|
|
|
|
cellular response to tumor necrosis factor
|
GO:0071356 |
21 |
0.636
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.632
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.625
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.625
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.625
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.624
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.622
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.619
|
|
|
|
regulation of metanephric mesenchymal cell migration
|
GO:2000589 |
2 |
0.618
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.617
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.615
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.614
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.614
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.613
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.613
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.612
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.610
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.605
|
|
|
|
regulation of metanephric mesenchymal cell migration by platelet derived growth factor receptor beta signaling pathway
|
GO:1900238 |
1 |
0.602
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.601
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.599
|
|
|
|
angiogenesis involved in coronary vascular morphogenesis
|
GO:0060978 |
2 |
0.599
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.598
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.597
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.597
|
|
|
|
regulation of odontogenesis
|
GO:0042481 |
18 |
0.588
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.586
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.586
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.585
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.582
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.582
|
|
|
|
response to sterol
|
GO:0036314 |
4 |
0.573
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.569
|
|
|
|
regulation of blood vessel remodeling
|
GO:0060312 |
3 |
0.567
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.563
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.556
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.555
|
|
|
|
osteoclast development
|
GO:0036035 |
9 |
0.554
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.553
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.552
|
|
|
|
response to progesterone
|
GO:0032570 |
1 |
0.552
|
|
|
|
cell cell junction maintenance
|
GO:0045217 |
3 |
0.552
|
|
|
|
cardiac myofibril assembly
|
GO:0055003 |
12 |
0.548
|
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
54 |
0.547
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.541
|
|
|
|
granulocyte chemotaxis
|
GO:0071621 |
39 |
0.539
|
|
|
|
exocrine system development
|
GO:0035272 |
45 |
0.535
|
|
|
|
cellular response to interferon gamma
|
GO:0071346 |
25 |
0.535
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.534
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.532
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.529
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.528
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.528
|
|
|
|
regulation of tyrosine phosphorylation of stat protein
|
GO:0042509 |
20 |
0.527
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.526
|
|
|
|
metanephric mesenchymal cell migration
|
GO:0035789 |
2 |
0.524
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.520
|
|
|
|
smooth muscle tissue development
|
GO:0048745 |
22 |
0.519
|
|
|
|
negative regulation of b cell activation
|
GO:0050869 |
27 |
0.518
|
|
|
|
myeloid progenitor cell differentiation
|
GO:0002318 |
8 |
0.518
|
|
|
|
response to tumor necrosis factor
|
GO:0034612 |
26 |
0.517
|
|
|
|
response to retinoic acid
|
GO:0032526 |
56 |
0.515
|
|
|
|
regulation of vitamin metabolic process
|
GO:0030656 |
3 |
0.514
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.513
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.513
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.511
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.509
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.506
|
|
|
|
myofibril assembly
|
GO:0030239 |
34 |
0.504
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.502
|
|
|
|
extrinsic apoptotic signaling pathway via death domain receptors
|
GO:0008625 |
34 |
0.501
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.501
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.499
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.499
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.497
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.496
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.495
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.490
|
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.490
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.490
|
|
|
|
pattern recognition receptor signaling pathway
|
GO:0002221 |
47 |
0.489
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.487
|
|
|
|
positive regulation of myeloid leukocyte differentiation
|
GO:0002763 |
26 |
0.485
|
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
41 |
0.485
|
|
|
|
peptidyl tyrosine autophosphorylation
|
GO:0038083 |
5 |
0.485
|
|
|
|
hair follicle cell proliferation
|
GO:0071335 |
3 |
0.485
|
|
|
|
positive regulation of glial cell proliferation
|
GO:0060252 |
4 |
0.484
|
|
|
|
chemical homeostasis within a tissue
|
GO:0048875 |
9 |
0.484
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
33 |
0.483
|
|
|
|
toll like receptor signaling pathway
|
GO:0002224 |
38 |
0.482
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.481
|
|
|
|
type i interferon signaling pathway
|
GO:0060337 |
10 |
0.478
|
|
|
|
osteoblast development
|
GO:0002076 |
17 |
0.474
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.473
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.472
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.470
|
|
|
|
olfactory learning
|
GO:0008355 |
2 |
0.469
|
|
|
|
macrophage chemotaxis
|
GO:0048246 |
14 |
0.467
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.467
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.466
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.465
|
|
|
|
activation of innate immune response
|
GO:0002218 |
56 |
0.464
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.464
|
|
|
|
positive regulation of jun kinase activity
|
GO:0043507 |
30 |
0.463
|
|
|
|
multicellular organismal macromolecule metabolic process
|
GO:0044259 |
19 |
0.462
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.459
|
|
|
|
blood vessel endothelial cell migration
|
GO:0043534 |
23 |
0.459
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.459
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.458
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.456
|
|
|
|
response to erythropoietin
|
GO:0036017 |
1 |
0.455
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.454
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.454
|
|
|
|
positive regulation of binding
|
GO:0051099 |
49 |
0.451
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.450
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.450
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.449
|
|
|
|
defense response to gram negative bacterium
|
GO:0050829 |
28 |
0.448
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.448
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.448
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.447
|
|
|
|
metanephric glomerulus vasculature morphogenesis
|
GO:0072276 |
3 |
0.447
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.446
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.446
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.446
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.445
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.444
|
|
|
|
mucopolysaccharide metabolic process
|
GO:1903510 |
25 |
0.444
|
|
|
|
head morphogenesis
|
GO:0060323 |
34 |
0.443
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.442
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.441
|
|
|
|
tolerance induction
|
GO:0002507 |
14 |
0.441
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.440
|
|
|
|
positive regulation of vasculogenesis
|
GO:2001214 |
7 |
0.439
|
|
|
|
vascular endothelial growth factor signaling pathway
|
GO:0038084 |
10 |
0.438
|
|
|
|
regulation of phospholipase c activity
|
GO:1900274 |
3 |
0.438
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.437
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.436
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.434
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.434
|
|
|
|
aminoglycan metabolic process
|
GO:0006022 |
34 |
0.434
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.429
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.427
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.426
|
|
|
|
regulation of jak stat cascade
|
GO:0046425 |
34 |
0.421
|
|
|
|
response to glucocorticoid
|
GO:0051384 |
20 |
0.421
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.417
|
|
|
|
positive regulation of leukocyte apoptotic process
|
GO:2000108 |
21 |
0.417
|
|
|
|
kidney vasculature development
|
GO:0061440 |
15 |
0.416
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway
|
GO:2001238 |
34 |
0.416
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.416
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.416
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
45 |
0.413
|
|
|
|
face development
|
GO:0060324 |
38 |
0.413
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.413
|
|
|
|
modification of morphology or physiology of other organism involved in symbiotic interaction
|
GO:0051817 |
16 |
0.413
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.412
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.409
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.408
|
|
|
|
kit signaling pathway
|
GO:0038109 |
3 |
0.406
|
|
|
|
regulation of myoblast differentiation
|
GO:0045661 |
29 |
0.406
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.405
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.405
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.404
|
|
|
|
immature b cell differentiation
|
GO:0002327 |
10 |
0.404
|
|
|
|
memory
|
GO:0007613 |
58 |
0.403
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.401
|
|
|
|
regulation of vasculogenesis
|
GO:2001212 |
9 |
0.401
|
|
|
|
response to stem cell factor
|
GO:0036215 |
3 |
0.401
|
|
|
|
smooth muscle cell chemotaxis
|
GO:0071670 |
2 |
0.400
|
|
|
|
regulation of fibroblast proliferation
|
GO:0048145 |
34 |
0.400
|
|
|
|
erythropoietin mediated signaling pathway
|
GO:0038162 |
1 |
0.398
|
|
|
|
cellular response to vitamin
|
GO:0071295 |
2 |
0.387
|
|
|
|
positive regulation of immunoglobulin production
|
GO:0002639 |
28 |
0.385
|
|
|
|
negative regulation of phagocytosis
|
GO:0050765 |
4 |
0.385
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.384
|
|
|
|
cell migration involved in sprouting angiogenesis
|
GO:0002042 |
9 |
0.382
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.382
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.381
|
|
|
|
regulation of alpha beta t cell proliferation
|
GO:0046640 |
18 |
0.380
|
|
|
|
melanocyte migration
|
GO:0097324 |
2 |
0.376
|
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
47 |
0.376
|
|
|
|
pro t cell differentiation
|
GO:0002572 |
3 |
0.376
|
|
|
|
regulation of lipid kinase activity
|
GO:0043550 |
14 |
0.374
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.373
|
|
|
|
positive regulation of production of molecular mediator of immune response
|
GO:0002702 |
45 |
0.372
|
|
|
|
glomerulus development
|
GO:0032835 |
40 |
0.369
|
|
|
|
tolerance induction to self antigen
|
GO:0002513 |
4 |
0.368
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.368
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.367
|
|
|
|
cd4 positive alpha beta t cell activation
|
GO:0035710 |
45 |
0.366
|
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
60 |
0.363
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.362
|
|
|
|
growth plate cartilage development
|
GO:0003417 |
14 |
0.362
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.361
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.361
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.361
|
|
|
|
branching involved in mammary gland duct morphogenesis
|
GO:0060444 |
27 |
0.361
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.361
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.360
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.359
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.358
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.356
|
|
|
|
positive regulation of neuron apoptotic process
|
GO:0043525 |
25 |
0.355
|
|
|
|
positive regulation of macrophage chemotaxis
|
GO:0010759 |
5 |
0.354
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.354
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.353
|
|
|
|
tooth mineralization
|
GO:0034505 |
9 |
0.353
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.353
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.352
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.351
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.350
|
|
